Transplantation in the Alcoholic Patient

Alcoholic liver disease (ALD) is the second leading indication for transplantation in the United States. Most transplant programs in the United States require a minimum of 6 month's abstinence before transplantation is performed. Most studies have shown a recidivism rate of between 20 and 30% by 2 years after orthotopic liver transplantation (OLT). Higher rates of recidivism are reported if pre-OLT abstinence was < 6 months. The impact of recidivism on patient and graft survival is not clear because most reports include patients who consume alcohol in small amounts or infrequently. Equal post-OLT survival for ALD patients and non-ALD patients has been demonstrated, and ALD patients are not thought to suffer greater morbidity post transplant than non-ALD patients. Careful pretransplant assessment for concomitant medical and psychosocial ailments associated with alcoholism is important. Posttransplant monitoring for cardiovascular disease and withdrawal syndromes is required in the early postoperative setting, whereas monitoring for recidivism and malignancy are late postoperative issues.

Alcohol - liver disease - and transplantation

REFERENCES

• 1 Keefe E B. Milestones in liver transplantation for alcoholic liver disease.  Liver Transpl Surg. 1997;  3 197-198
• 2 Starzl T E, Van Thiel D, Tzakis A G et al.. Orthotopic liver transplantation for alcoholic cirrhosis.  JAMA. 1988;  260 2542-2544
• 3 Wiesner R H, Lombardero M, Lake J R et al.. Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes.  Liver Transpl Surg. 1997;  3 231-239
• 4 Keefe E B. Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome and recidivism.  Liver Transpl Surg. 1996;  2 12-20
• 5 Belle S H, Beringer K C, Detre K M. Liver transplantation for alcoholic liver disease in the United States: 1988-1995.  Liver Transpl Surg. 1997;  3 212-219
• 6 Neuberger J, Schulz K H, Day C et al.. Transplantation for alcoholic liver disease.  J Hepatol. 2002;  36 130-137
• 7 Hoofnagle J H, Kresina T, Fuller R K, Lake J R. Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health Workshop held December 6-7, 1996 Bethesda, Maryland.  Liver Transpl Surg. 1997;  3 347-350
• 8 Kearns P J, Young H, Garcia G et al.. Accelerated improvement of alcoholic liver disease with enteral nutrition.  Gastroenterology. 1992;  102 200-205
• 9 Howard L, Fahy T, Wong P et al.. Psychiatric outcome in alcoholic liver transplant patients.  Q J Med. 1994;  87 731-736
• 10 Gish R G, Lee A, Brooks L et al.. Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation.  Liver Transpl. 2001;  7 581-587
• 11 Everhart J E, Beresford T P. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States.  Liver Transpl Surg. 1997;  3 220-226
• 12 Keefe E B. Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation.  Liver Transpl Surg. 1997;  3 251-257
• 13 Lucey M R. Liver transplantation in the alcoholic patient. In: Maddrey WC, Schiff EE, Sorrell MF Transplantation of the Liver. Philadelphia; Lippincott Williams and Wilkins 2001: 319-326
• 14 Kryzhanovski V A, Beller G A. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation.  Am J Cardiol. 1997;  79 986-988
• 15 Zoghbi G J, Patel A D, Ershadi R E et al.. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation.  Am J Cardiol. 2003;  92 1066-1071
• 16 Donovan C L, Marcovitz P A, Punch J D et al.. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.  Transplantation. 1996;  61 1180-1188
• 17 Plotkin J S, Benitez R M, Kuo P C et al.. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation.  Liver Transpl Surg. 1998;  4 252-257
• 18 Williams K, Lewis J F, Davis G, Geiser E A. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation.  Transplantation. 2000;  69 2354-2356
• 19 Keefe B G, Valantine H, Keefe E B. Detection and treatment of coronary artery disease in liver transplant candidates.  Liver Transpl. 2001;  7 755-761
• 20 Plotkin J S, Johnson L B, Rustgi V, Kuo P C. Coronary artery disease and liver transplantation: The state of the art.  Liver Transpl. 2000;  6(Suppl 1) S53-S56
• 21 Kenngott S, Gerbes A L, Schauer R, Bilzer M. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis.  Transpl Int. 2003;  16 639-641
• 22 Duvoux C, Delacroix I, Richardet J P et al.. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis.  Transplantation. 1999;  67 418-421
• 23 Degos F. Hepatitis C and alcohol.  J Hepatol. 1999;  31(Suppl 1) 113-118
• 24 Schiff E R. The alcoholic patient with hepatitis C virus infection.  Am J Med. 1999;  27 95S-99S
• 25 Wiley T E, McCarthy M, Breidi L et al.. Impact of alcohol on the histological and clinical progression of hepatitis C infection.  Hepatology. 1998;  28 805-809
• 26 Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C.  Lancet. 1997;  349 825-832
• 27 Pessione F, Degos F, Marcellin P et al.. Effect of alcohol consumption on serum hepatitis C virus RNA and histologic lesions in chronic hepatitis C.  Hepatology. 1998;  27 1717-1722
• 28 Corrao G, Aricos S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis.  Hepatology. 1998;  27 914-919
• 29 Ostapowicz G, Watson K JR, Locarnini S A, Desmond P V. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection.  Hepatology. 1998;  27 1730-1735
• 30 Anderson S, Nevins C L, Green L K et al.. Assessment of liver histology in chronic alcoholics with and without hepatits C virus infection.  Dig Dis Sci. 2001;  46 1393-1398
• 31 Yamanaka T, Shiraki K, Nakazaawa S et al.. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.  Anticancer Res. 2001;  21 2937-2940
• 32 Yamauchi M, Nakahara M, Maezawa Y et al.. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.  Am J Gastroenterol. 1993;  88 39-43
• 33 Donato F, Tagger A, Chiesa R et al.. Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma: a case control study in Italy.  Hepatology. 1997;  26 579-584
• 34 Mackie J, Groves K, Hoyle A et al.. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism and risk factors predisposing to recidivism.  Liver Transpl. 2001;  7 418-427
• 35 Platz K P, Mueller A R, Spree E et al.. Liver transplantation for alcoholic cirrhosis.  Transpl Int. 2000;  13(Suppl 1) S127-S130
• 36 Veldt B J, Laine F, Guillygomarc'h A et al.. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing.  J Hepatol. 2002;  36 93-98
• 37 Pageaux G P, Michel J, Coste V et al.. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism.  Gut. 1999;  45 421-426
• 38 Bravata D M, Olkin I, Barnato A E et al.. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review.  Liver Transpl. 2001;  7 191-203
• 39 Vaillant G E. The natural history of alcoholism and its relationship to liver transplantation.  Liver Transpl Surg. 1997;  3 304-310
• 40 Yates W R, Martin M, LaBrecque D et al.. A model to examine the validity of the 6-month abstinence criterion for liver transplantation.  Alcohol Clin Exp Res. 1998;  22 513-517
• 41 Tome S, Lucey M R. Timing of liver transplantation in alcoholic cirrhosis.  J Hepatol. 2003;  39 302-307
• 42 Poynard T, Naveau S, Doffoel M et al.. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-Centre Group.  J Hepatol. 1999;  30 1130-1137
• 43 Everson G T, Bharadhwaj G, House R et al.. Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation.  Liver Transpl Surg. 1997;  3 263-274
• 44 Farges O, Saliba F, Farmahant H et al.. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.  Hepatology. 1996;  23 240-248
• 45 Pageaux G P, Bismuth M, Perney P et al.. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?.  J Hepatol. 2003;  38 629-634
• 46 Burra P, Mioni D, Cecchetto A et al.. Histological features after liver transplantation in alcoholic cirrhotics.  J Hepatol. 2001;  34 716-722
• 47 Savolainen V, Perola M, Lalu K et al.. Early perivenular fibrogenesis - precirrhotic lesions among moderate alcohol consumers and chronic alcoholics.  J Hepatol. 1995;  23 524-531
• 48 Conjeevaram H S, Hart J, Lissoos T W et al.. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients.  Transplantation. 1999;  67 1562-1568
• 49 McCurry K R, Baliga P, Merion R M et al.. Resource utilization and outcome of liver transplantation for alcoholic cirrhosis. A case-control study.  Arch Surg. 1992;  127 772-777
• 50 Gerhardt T C, Goldstein R M, Urschel H C et al.. Alcohol use following liver transplantation for alcoholic cirrhosis.  Transplantation. 1996;  62 1060-1063
• 51 Fabrega E, Crespo J, Casafont F et al.. Alcoholic recidivism after liver transplantation for alcoholic cirrhosis.  J Clin Gastroenterol. 1998;  26 204-206
• 52 Osorio R W, Ascher N L, Avery M et al.. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease.  Hepatology. 1994;  20 105-110
• 53 Tang H, Boulton R, Gunson B et al.. Patterns of alcohol consumption after liver transplantation.  Gut. 1998;  43 140-145
• 54 Shakil A O, Pinna A, Demetris J et al.. Survival and quality of life after liver transplantation for acute alcoholic hepatitis.  Liver Transpl Surg. 1997;  3 240-244
• 55 Tome S, Martinez-Rey C, Gonzalez-Quintela A et al.. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease.  J Hepatol. 2002;  36 793-798
• 56 Bonet H, Manez R, Kramer D et al.. Liver transplantation for alcoholic liver disease: survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone.  Alcohol Clin Exp Res. 1993;  17 1102-1106
• 57 Lucey M R. Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?.  J Hepatol. 2002;  36 829-831